Healthcare DIVE November 13, 2024
The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.
Dive Brief:
- Johnson & Johnson is suing the Biden administration for blocking a controversial change to how the pharmaceutical company divvies out drug discounts to hospitals in a federal savings program.
- This summer, J&J unveiled a plan to give hospitals after-the-fact rebates for two medications in the program, called 340B, instead of upfront discounts, but paused implementation following threats of government sanctions. The lawsuit filed Tuesday in a district court seeks a ruling finding J&J’s plan legal and allowing the drugmaker to roll out the model.
- It’s the latest salvo...
Today's Sponsors
Today's Sponsor